Breast cancer morbidity and mortality rates in the Republic of Dagestan

O M Magomedov; O M Magomedov

doi:10.17816/onco39854

Russian Journal of Oncology ›› 2011, Vol. 16 ›› Issue (3) : 36 -39. DOI: 10.17816/onco39854

Articles

other

Breast cancer morbidity and mortality rates in the Republic of Dagestan

Author information +

History +

PDF

Abstract

Breast cancer (BC) morbidity and mortality rates were analyzed in the Republic of Dagestan (RD) for a long period (1991-2002) and their current state was assessed. The standardized (world standard for) rate of BC morbidity in the RD was found to be 22.9 and, as a whole, significantly lower than the average rate in the Russian Federation (41.6%) and that of morbidity was 14.1 and inconsistent with the official data. It was also ascertained that both rates in the RD were increasing and varied within this republic with the female residence (urban, rural, geographic zone). Thus, the morbidity and mortality rates among the urban women (32.1 and 19.7) and in the lowlands (27.7 and 18.0) was twice as high as in the rural (15.8 and 10) and highlands (12.7 and 8.5). Cities, towns, and areas with high and low BC morbidity and mortality rates were defined. In some of them the BC mortality rates were also established to be greater than not only average republican, but also average federative ones. It was concluded that this situation was due to poor detection and the absence of primary and secondary prevention measures and screening programs. The impact of inadequate scope of treatment performed in the Dagestan Republican Cancer Dispensary on the rates is not ruled out either.

Keywords

breast cancer / morbidity / mortality / Republic of Dagestan / lowlands / foothills / mountains / city / town / village / age

Cite this article

Download citation ▾

O M Magomedov, O M Magomedov. Breast cancer morbidity and mortality rates in the Republic of Dagestan. Russian Journal of Oncology, 2011, 16(3): 36-39 DOI:10.17816/onco39854

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Беспалов В. Г., Аксенов А. В., Овсяников А. И. и др. // Вопр. онкол. - 1998. - № 1. - С. 86-91.

[2]	Заридзе Д. Г., Мень Т. Х. // Рос. онкол. журн. - 2001. - № 5. - С. 5-14.

[3]	Заридзе Д. Г. // Вопр. онкол. - 2002. - № 4-5. - С. 489-495.

[4]	Заридзе Д. Г. // Энциклопедия клинической онкологии: Руководство для практикующих врачей / Под ред. М. И. Давыдова, Г. Л. Вышковского. - М., 2004. - С. 69-71.

[5]	Злокачественные новообразования в России в 2006 г. (заболеваемость и смертность) / Под ред. В. И. Чиссова и др. - М., 2008.

[6]	Крутяков В. М. // Вопр. онкол. - 2001. - № 1. - С. 106- 108.

[7]	Семиглазов В. Ф., Нургазиев К. Ш., Арзуманов А. С. Опухоли молочной железы (профилактика и лечение). - Алматы, 2001.

[8]	Сопоцинская Е. Б., Балицкий К. П., Тарутинов В. И. и др. // Вопр. онкол. - 1992. - № 4-6. - С. 592-598.

[9]	Статистика злокачественных новообразований в России и странах СНГ в 2006 г. / Под ред. М. И. Давыдова, Е. М. Аксель // Вестн. РОНЦ им. Н. Н. Блохина РАМН. - 2008. - Т. 19, № 2. - Прил. 1.